Frank D Kolodgie

CVPath Institute, Inc., Gaithersburg, MD, US

Articles by Frank D Kolodgie

HORIZONS and Drug-eluting Stent Usage in Acute Myocardial Infarction

Gaku Nakazawa, Masataka Nakano, Marc Vorpahl, et al

Citation: Interventional Cardiology 2009;4(1):53-6

DOI:

https://doi.org/10.15420/icr.2009.4.1.53
Pathology of First-generation Drug-eluting Stents in Humans

Fumiyuki Otsuka, Masataka Nakano, Saami K Yazdani, et al

Citation: Interventional Cardiology 2011;6(1):28–35

DOI:

https://doi.org/10.15420/icr.2011.6.1.28
Pathology of First-generation Drug-eluting Stents in Humans

Fumiyuki Otsuka, Masataka Nakano, Saami K Yazdani, et al

Citation: Asia-Pacific Cardiology 2011;3(1):52-9

DOI:

https://doi.org/10.15420/apc.2011:3:1:52
Pre-clinical and Clinical Study Results for the Coracto™ Rapamycin-eluting Stent – A New-generation Drug-eluting Stent

Nicolaus Reifart, Mariann Gyöngyösi, Karl-Eugen Hauptmann, et al

Citation: Interventional Cardiology 2010;5:39–42

DOI:

https://doi.org/10.15420/icr.2010.5.1.39